Literature DB >> 20437915

Impact of partial administration of the Cognitive Behavioral Driver's Inventory on concurrent validity for people with brain injury.

Josée Duquette1, Patricia McKinley, Barbara Mazer, Isabelle Gélinas, Marie Vanier, Dana Benoit, Jacques Gresset.   

Abstract

OBJECTIVES: We sought to determine whether the partial administration of the Cognitive Behavioral Driver's Inventory (CBDI) has a significant effect on its concurrent validity.
METHOD: Data were extracted from charts of clients with cerebrovascular accident or traumatic brain injury from three centers. The CBDI was administered either completely or partially (right and left perimetry or Wechsler Adult Intelligence Scale-Revised (WAIS-R; Wechsler, 1982; Picture Completion and Digit Symbol tests were not completed). Concurrent validity indicators were calculated for the CBDI and three different scenarios of partial administration of the CBDI.
RESULTS: Only 52% of the road test failures were predicted correctly by the completely administered CBDI. Nonadministration of the WAIS-R rarely modified the CBDI results. Omission of perimetry scores tended to increase the sensitivity and decrease the specificity (not significantly).
CONCLUSION: The CBDI should be used as a complement, not a substitution, for a road test. Partially administrating the CBDI, specifically excluding perimetry measures, can affect its concurrent validity.

Entities:  

Mesh:

Year:  2010        PMID: 20437915     DOI: 10.5014/ajot.64.2.279

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  2 in total

1.  Driving difficulties and adaptive strategies: the perception of individuals having sustained a mild traumatic brain injury.

Authors:  Carolina Bottari; Marie-Pierre Lamothe; Nadia Gosselin; Isabelle Gélinas; Alain Ptito
Journal:  Rehabil Res Pract       Date:  2012-02-13

2.  Driver safety in patients with primary brain tumors.

Authors:  Eduardo Estevis; Kyle R Noll; Mariana E Bradshaw; Jeffrey S Wefel
Journal:  Neurooncol Pract       Date:  2019-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.